Hsbc Holdings PLC Purchases Shares of 80,307 Neogen Corporation $NEOG

Hsbc Holdings PLC acquired a new position in Neogen Corporation (NASDAQ:NEOG) in the first quarter, according to the company in its most recent filing with the SEC. The firm acquired 80,307 shares of the company’s stock, valued at approximately $734,000.

Several other institutional investors also recently modified their holdings of the company. T. Rowe Price Investment Management Inc. increased its position in shares of Neogen by 249.2% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 8,181,768 shares of the company’s stock valued at $57,191,000 after purchasing an additional 5,838,570 shares during the period. Mackenzie Financial Corp lifted its position in Neogen by 1.0% in the fourth quarter. Mackenzie Financial Corp now owns 7,898,439 shares of the company’s stock worth $55,574,000 after purchasing an additional 79,010 shares during the period. Cibc World Markets Corp bought a new position in Neogen in the fourth quarter worth $47,983,000. Hudson Bay Capital Management LP boosted its stake in Neogen by 30.0% during the fourth quarter. Hudson Bay Capital Management LP now owns 6,500,000 shares of the company’s stock worth $45,435,000 after buying an additional 1,500,000 shares in the last quarter. Finally, SG Americas Securities LLC increased its holdings in Neogen by 287.4% in the 1st quarter. SG Americas Securities LLC now owns 6,266,033 shares of the company’s stock valued at $58,211,000 after buying an additional 4,648,436 shares during the period. Institutional investors and hedge funds own 96.73% of the company’s stock.

Wall Street Analysts Forecast Growth

NEOG has been the subject of a number of analyst reports. Wall Street Zen raised shares of Neogen from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Weiss Ratings cut shares of Neogen from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Friday, July 24th. Two equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Neogen has a consensus rating of “Hold” and a consensus target price of $10.67.

Key Headlines Impacting Neogen

Here are the key news stories impacting Neogen this week:

• Positive Sentiment: Quarterly results exceeded expectations: Neogen reported fiscal Q4 earnings of $0.09 per share, versus the $0.05 consensus estimate, while revenue of $225.3 million surpassed expectations of $212.35 million. The earnings result also improved substantially from the prior-year loss. Neogen Beats Q4 Earnings and Revenue Estimates
• Positive Sentiment: Above-consensus outlook: Management forecast fiscal 2027 revenue of $880 million to $885 million, well above the roughly $851.1 million analyst consensus. First-quarter fiscal 2027 revenue guidance of $207 million to $209 million also topped the $204.9 million consensus. The company outlined adjusted EBITDA guidance of $180 million to $182 million for fiscal 2027. Neogen Fiscal 2027 Outlook
• Neutral Sentiment: Investment may weigh on near-term profitability: Neogen plans to increase research and development spending by about 50%, signaling continued investment in future growth but potentially limiting margin expansion in the near term. Neogen Q4 Earnings Call Transcript
• Negative Sentiment: Revenue growth remained muted: Fiscal Q4 revenue was essentially flat year over year, declining 0.1%, so the stock’s positive reaction depends heavily on the earnings beat and forward guidance rather than current top-line growth.

Neogen Price Performance

Shares of NEOG stock opened at $11.53 on Friday. The stock’s fifty day simple moving average is $9.37 and its 200 day simple moving average is $9.60. The company has a debt-to-equity ratio of 0.38, a current ratio of 3.92 and a quick ratio of 2.84. The firm has a market cap of $2.51 billion, a price-to-earnings ratio of -4.12, a P/E/G ratio of 4.21 and a beta of 1.80. Neogen Corporation has a one year low of $4.56 and a one year high of $11.56.

Neogen (NASDAQ:NEOG) last announced its quarterly earnings results on Thursday, July 30th. The company reported $0.09 earnings per share for the quarter, beating analysts’ consensus estimates of $0.05 by $0.04. The firm had revenue of $225.30 million for the quarter, compared to analysts’ expectations of $212.35 million. Neogen had a positive return on equity of 2.35% and a negative net margin of 69.93%.The business’s revenue was down .1% compared to the same quarter last year. During the same period in the prior year, the business posted ($2.82) earnings per share. On average, analysts expect that Neogen Corporation will post 0.23 earnings per share for the current fiscal year.

About Neogen

Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user‐friendly assays to food processors, grain handlers and quality laboratories around the world.

In the food safety arena, Neogen’s product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E.